94% of Surveyed CDOs State Optimized Data Privacy Technology Leads to Increased Revenues, New TripleBlind Survey Reveals

Nearly Half of Healthcare and Financial Services Executives Believe Enhanced PET Solutions Give Their Organizations a Competitive Advantage

In a new survey released today by TripleBlind, 94% of CDOs from healthcare organizations and financial service firms stated deploying data privacy technology that enforces existing data privacy regulations would result in increased revenues for their organizations. 37% of respondents stated they estimate improved collaboration would increase revenues as much as 20%. In addition, 46% stated increased data collaboration would give their organization a competitive advantage over other organizations. TripleBlind is creator of the most complete and scalable solution for privacy enhancing computation.

Additional key findings of the survey included:

  • 64% of respondents are concerned that employees at organizations with which they are collaborating will use data in a way not authorized in signed legal agreements,
  • 60% are concerned people at organizations with which they collaborate will use data that violates HIPAA and/or other data privacy regulations,
  • 60% are concerned that the privacy-enhancing technology (PET) solution deployed by data collaboration partners will modify the data to make the results of analyses inaccurate.

“There is strong agreement that optimizing effective data collaboration through advanced PET solutions will result in both increased revenues and enhanced competitive advantage,” said Riddhiman Das, TripleBlind’s Co-founder and CEO. “Today, advanced PET solutions exist that render legal agreements obsolete and prevent people at both the data user and data owner from using data in a way that violates HIPAA and other data privacy regulations or modifies data in a way that results in inaccurate analyses.”

Marketing Technology News: Datawisp Closes $3.6M Seed Round Led by CoinFund to Expand its B2B no-code Data Platform for Web3…

Healthcare Organizations Especially Concerned about Regulatory Compliance and Accuracy

Healthcare organizations represented in the survey include hospitals, healthcare systems, pharmaceutical manufacturers and health insurance companies. In terms of the value of enhanced data privacy to these organizations, 43% of healthcare system respondents believe it would result in increased revenues of up to 20%, an additional 48% believe up to 10%. 52% and 50% of healthcare system and hospital respondents, respectively, stated expanded data collaboration would give their organizations a competitive advantage.

The level of concern about people at data user organizations using data in a way that violates HIPAA and/or other data privacy regulations varies among different healthcare organizations. This was of great concern to healthcare insurance carriers with 86% citing this concern, as well as to 71% of hospital respondents, and 50% of healthcare systems respondents. 75% of healthcare system respondents were also concerned that data user organizations had installed PET solutions that would make the results of analyses inaccurate, 73% of pharma manufacturers and 60% of hospital respondents shared this concern.

Financial Services Firms are Optimistic about the Potential of Improved Data Collaboration

Financial services firms included in the survey are banks, broker/dealers and credit card issuers. 60% of broker/dealer CDOs/senior data managers state improved data collaboration practices would include revenues up to 20%, while 59% of bank executives had the same response. Half of broker dealers, 47% of banks and 44% of credit card issuer respondents believe enhanced data sharing would create a competitive advantage for their organizations.

Regarding use of data, financial institutions are somewhat less alarmist than their healthcare counterparts. 67% of credit card issuers and 63% of bank respondents are concerned that people at data user organizations will use data in a way that violates one or more data privacy regulations. And 50% of broker/dealer respondents are concerned people at data user organizations will deploy PET solutions that modify data to make analyses inaccurate, along with just 27% of bank and 25% of credit card issuer respondents.

Marketing Technology News: MarTech Interview With Emmanuel Cohen, Head of Marketing at Walnut

buy modafinil where to buy modafinil
instant payday loans online guaranteed approval no denial payday loans direct lenders only